N ov 2 00 8 Reaction mechanisms in 24 Mg + 12 C and 32 S + 24 Mg
نویسنده
چکیده
The occurence of “exotic” shapes in light N=Z α-like nuclei is investigated for 24Mg+12C and 32S+24Mg. Various approaches of superdeformed and hyperdeformed bands associated with quasimolecular resonant structures with low spin are presented. For both reactions, exclusive data were collected with the Binary Reaction Spectrometer in coincidence with EUROBALL IV installed at the VIVITRON Tandem facility of Strasbourg. Specific structures with large deformation were selectively populated in binary reactions and their associated γ-decays studied. The analysis of the binary and ternary reaction channels is discussed.
منابع مشابه
2 7 N ov 2 00 8 Reaction mechanisms in 24 Mg + 12 C and 32 S + 24 Mg
The occurence of “exotic” shapes in light N=Z α-like nuclei is investigated for 24Mg+12C and 32S+24Mg. Various approaches of superdeformed and hyperdeformed bands associated with quasimolecular resonant structures with low spin are presented. For both reactions, exclusive data were collected with the Binary Reaction Spectrometer in coincidence with EUROBALL IV installed at the VIVITRON Tandem f...
متن کاملEffect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia
OBJECTIVES The objective of this study is to report the dose response in ODYSSEY phase 3 clinical trials of proprotein convertase subtilisin kexin type 9 inhibition with alirocumab in patients not at prespecified lipid goals who received a per-protocol dose increase from 75 every 2 weeks (Q2W) to 150 mg Q2W. METHODS Patients (n=2181) receiving statins were enrolled in six phase 3 randomized, ...
متن کاملLipid‐lowering efficacy and safety of alirocumab in patients with or without diabetes: A sub‐analysis of ODYSSEY COMBO II
AIM This sub-analysis of the ODYSSEY COMBO II study compared the effects of alirocumab, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in high cardiovascular risk patients with or without diabetes mellitus (DM) receiving maximally tolerated statin therapy. METHODS COMBO II was a 104-week, double-blind study (n = 720) enrolling patients with documented atherosclerotic cardi...
متن کاملObservation of the Top Quark.
S. Abachi,12 B. Abbott,33 M. Abolins,23 B. S. Acharya,40 I. Adam,10 D. L. Adams,34 M. Adams,15 S. Ahn,12 H. Aihara,20 J. Alitti,36 G. Álvarez,16 G. A. Alves,8 E. Amidi,27 N. Amos,22 E. W. Anderson,17 S. H. Aronson,3 R. Astur,38 R. E. Avery,29 A. Baden,21 V. Balamurali,30 J. Balderston,14 B. Baldin,12 J. Bantly,4 J. F. Bartlett,12 K. Bazizi,7 J. Bendich,20 S. B. Beri,31 I. Bertram,34 V. A. Bezzu...
متن کاملTwenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
Nine healthy volunteers were studied on the seventh day of dosing at 21:00 h with nizatidine 150 mg (N 150), nizatidine 300 mg (N 300), ranitidine 300 mg (R 300), or placebo, given in a predetermined random order. The double-blind 24 hour studies, using the Royal Free Hospital standard protocol, simultaneously measured intragastric acidity and plasma gastrin concentration. Compared with placebo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2009